Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1997; 77(03): 606-608
DOI: 10.1055/s-0038-1656017
DOI: 10.1055/s-0038-1656017
Letter to the Editor
Plasmatic Plasminogen Activator Inhibitor Activity in Patients with Primary Breast Cancer
Further Information
Publication History
Received 16 September 1996
Accepted after revision 06 November 1996
Publication Date:
11 July 2018 (online)
-
References
- 1 Niwano H, Takahashi H, Taewaki W, Wada K, Seki Y, Shibata A. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states. Blood Coagulation and Fibrinolysis 1992; 3: 0389-0393
- 2 Pappot H, Gardsvoll H, Perdersen AN, Grondahl-Hansen J, Pyke C, Brunner N. Plasminogen Activator Inhibitor 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe Seyler 1995; 376: 0259-0269
- 3 de JongE, Knot EAR, Iburg AHC, Rijken DC, Veenhof KHN, Dooijewaard G, ten CasteJW. Increased plasminogen activator inhibition levels in malignancy. Thromb Haemost 1987; 57: 0140-0143
- 4 Newland JR, Haire WD. Elevated Plasminogen Activator Inhibitor levels found in patients with malignant conditions. Am J Clin Pathol 1991; 96: 0602-0604
- 5 Rocha E, Páramo JA, Fernández FJ, Cuesta B, Hernández M, Paloma MJ, Rifón J. Clotting activation and impairement of fibrinolysis in malignancy. Thrombosis Research 1989; 54: 0699-0707
- 6 von Tempelhoff G-F. Changes of hemorheology and clotting in different gynecologic malignancies. Clin Hemorheology 1995; 54: 0261-0262
- 7 Kwaan HC. The plasminogen-plasmin system in malignancy. Cancer and Metastasis Reviews 1992; 11: 0291-0311
- 8 Casslén B, Bossmar T, Lecander I, Astedt B. Plasminogen activators and plasminogen activator inhibitors in blood and tumor fluids of patients with ovarian cancer. Eur J Cancer 1994; 30 A: 1302-1309